This paper explores the relationship between open innovation (OI) and firm's network position on enhancing firm's innovation performance, such as new product development (NPD). We build a theoretical framework and test it on the biopharmaceutical context. Our result shows how firm's network position influences NPD performance obtained through OI practices.
|Numero di pagine||10|
|Stato di pubblicazione||Published - 2013|